Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teun van Gelder

Showing results (61-70 of 324) with videos related to

Pageof 33
Sort By:
Clinical Pharmacokinetics|September 24, 2005
Population pharmacokinetics of mycophenolic acid in renal transplant recipientsReinier M van Hest, Teun van Gelder, Arnold G Vulto, et al.
Journal of the American Medical Directors Association|February 22, 2026
Current Practice of Palliative Sedation in Dutch Nursing HomesJacqueline Wallage, Miriam L Haaksma, Teun van Gelder, et al.
Pharmacoepidemiology and Drug Safety|July 7, 2009
Drug safety alert generation and overriding in a large Dutch university medical centreHeleen van der Sijs, Alexandra Mulder, Teun van Gelder, et al.
NDT Plus|May 8, 2015
Polymorphisms of the glucocorticoid receptor and avascular necrosis of the femoral heads after treatment with corticosteroidsRachida Bouamar, Jan Willem Koper, Elisabeth F C van Rossum, et al.
Transplantation|February 28, 2003
Living kidney donors and hypoxia-inducible factor-1alphaCarla Baan, Teun van Gelder, Annemiek Peeters, et al.
Drugs & Aging|February 9, 2008
Increasing exposure to drug-drug interactions between 1992 and 2005 in people aged > or = 55 yearsMatthijs L Becker, Loes E Visser, Teun van Gelder, et al.
Pharmacogenomics|December 21, 2012
CYP3A4*22: promising newly identified CYP3A4 variant allele for personalizing pharmacotherapyLaure Elens, Teun van Gelder, Dennis A Hesselink, et al.
Pharmacogenetics and Genomics|October 12, 2013
Single-nucleotide polymorphisms in P450 oxidoreductase and peroxisome proliferator-activated receptor-α are associated with the development of new-onset diabetes after transplantation in kidney transplant recipients treated with tacrolimusLaure Elens, Ferdi Sombogaard, Dennis A Hesselink, et al.
Pharmacoepidemiology and Drug Safety|September 20, 2017
Media attention regarding sudden cardiac death associated with domperidone use does not affect in hospital ECG recordingFlorine Berger, Selma Saâïd, Teun van Gelder, et al.
International Journal of Medical Informatics|February 13, 2010
Functionality test for drug safety alerting in computerized physician order entry systemsHeleen van der Sijs, Rachida Bouamar, Teun van Gelder, et al.
Pageof 33

Showing results (61-70 of 324) with videos related to

Sort By:
Pageof 33
Clinical Pharmacokinetics|September 24, 2005
Population pharmacokinetics of mycophenolic acid in renal transplant recipientsReinier M van Hest, Teun van Gelder, Arnold G Vulto, et al.
Journal of the American Medical Directors Association|February 22, 2026
Current Practice of Palliative Sedation in Dutch Nursing HomesJacqueline Wallage, Miriam L Haaksma, Teun van Gelder, et al.
Pharmacoepidemiology and Drug Safety|July 7, 2009
Drug safety alert generation and overriding in a large Dutch university medical centreHeleen van der Sijs, Alexandra Mulder, Teun van Gelder, et al.
NDT Plus|May 8, 2015
Polymorphisms of the glucocorticoid receptor and avascular necrosis of the femoral heads after treatment with corticosteroidsRachida Bouamar, Jan Willem Koper, Elisabeth F C van Rossum, et al.
Transplantation|February 28, 2003
Living kidney donors and hypoxia-inducible factor-1alphaCarla Baan, Teun van Gelder, Annemiek Peeters, et al.
Drugs & Aging|February 9, 2008
Increasing exposure to drug-drug interactions between 1992 and 2005 in people aged > or = 55 yearsMatthijs L Becker, Loes E Visser, Teun van Gelder, et al.
Pharmacogenomics|December 21, 2012
CYP3A4*22: promising newly identified CYP3A4 variant allele for personalizing pharmacotherapyLaure Elens, Teun van Gelder, Dennis A Hesselink, et al.
Pharmacogenetics and Genomics|October 12, 2013
Single-nucleotide polymorphisms in P450 oxidoreductase and peroxisome proliferator-activated receptor-α are associated with the development of new-onset diabetes after transplantation in kidney transplant recipients treated with tacrolimusLaure Elens, Ferdi Sombogaard, Dennis A Hesselink, et al.
Pharmacoepidemiology and Drug Safety|September 20, 2017
Media attention regarding sudden cardiac death associated with domperidone use does not affect in hospital ECG recordingFlorine Berger, Selma Saâïd, Teun van Gelder, et al.
International Journal of Medical Informatics|February 13, 2010
Functionality test for drug safety alerting in computerized physician order entry systemsHeleen van der Sijs, Rachida Bouamar, Teun van Gelder, et al.
Pageof 33